Long-term case-fatality rate of nontuberculous mycobacterial disease in people living with HIV

Abstract

Background Few data are available regarding the long-term case-fatality rate (CFR) among people living with HIV (PLWH) with nontuberculous mycobacteria (NTM) disease. The aim of this study is to analyze the long-term CFR in patients with NTM disease and to identify risk factors for their death. Methods A retrospective cohort study of 379 cases of microbiologically confirmed NTM disease in PLWH was conducted from January 1, 2012, to December 31, 2020, in Shanghai, China. We used Kaplan–Meier survival analysis and the log-rank test to compare the long-term CFR in patients with disseminated NTM (DNTM) and localized NTM disease. Univariate Cox proportional hazards regression analysis and a stepwise Cox proportional hazards regression model were used to estimate the predictors of long-term CFR. Results The cohort was followed up for a median of 26 months. The total CFR was 15.7% by one year and increased to 22.6% at 5 years after the diagnosis of NTM disease. The 5-year CFR of PLWH with DNTM was significantly higher than that of PLWH with localized NTM (26.7% vs 19.6% for DNTM and localized NTM disease, respectively). Older age [hazard ratio (HR) = 1.04, 95% confidence interval (CI): 1.02–1.06, P < 0.001], comorbidity (HR = 2.05, 95% CI: 1.21–3.49, P < 0.01), DNTM (HR = 2.08, 95% CI: 1.17–3.68, P < 0.05), and HIV viral load (HR = 1.32, 95% CI: 1.12–1.55, P < 0.001) were all independent risk factors for long-term CFR. In the subgroup analysis, time to culture positivity was negatively correlated with CFR in patients with DNTM (HR = 0.90, 95% CI: 0.82–0.98, P < 0.05). Conclusions NTM was associated with a high long-term CFR in PLWH. Further approaches to prevent NTM disease in PLWH are urgently needed. Graphical Abstract

Research Clinical Analysis and Risk Factors Associated With a Poor Prognosis in Nontuberculous Mycobacterial Infection: An 8-year Retrospective Cohort Study

“…The incidence of NTM infection has been increasing globally, and several studies have provided high overall estimates for case fatality rates in patients with NTM pulmonary disease [15]. Hu et al [2] reported that the 5-year case fatality rates for people with HIV and NTM disease was 22.6%. A high mortality rate was also noted in this study, with a cumulative mortality rate of 14.9% at 1 year and 24.49% at 5 years.…”

Rare case of Rhodococcus hoagii bacteremia in an HIV late‑presenter with NTM pulmonary disease: A case report and review of the literature

“…These infections are challenging to manage, often requiring long-term, multidrug regimens that must be carefully coordinated with HIV treatment to avoid drug interactions. The presence of NTM at the initiation of anti-retroviral therapy (ART) can hinder CD4 + T-cell count recovery, complicating the overall treatment and prognosis (9)(10)(11)(12).…”

Impact factors of Blastocystis hominis infection in persons living with human immunodeficiency virus: a large-scale, multi-center observational study from China

“…Viral replication within patients' bodies is suppressed by initiating HAART, leading to an increase in the CD4 + T cell counts and the restoration of immune function. This approach has had a profound impact on reducing mortality associated with OPIs among PLWH [ 19 , 27 , 28 ]. However, certain PLWH who have been prescribed HAART may fail to achieve sufficient virological and immunological responses due to factors related to adherence, pharmacokinetics, or unknown biological factors [ 26 ].…”